ArticleBioresources and bioprocessing2026
Development of a new biological dressing: the modified cross-linking of Chitosan derived from cuttlefish (Sepia pharaonis) by-products as an effective agent for promoting cell migration.
Article in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aimed to extract chitosan (CS) from cuttlefish (Sepia pharaonis) bones (CB) and then chemically modify it to produce carboxymethyl chitosan (CMC). Marine cuttlefish skin collagen peptide (MCP) was then cross-linked with CMC to form a novel CMC-MCP complex. The physicochemical properties and biological effects of CS, CMC, MCP, and CMC-MCP were evaluated using human keratinocyte (HaCaT) cell lines. All materials showed cytotoxicity at high concentrations (100-1600 µg/mL), negatively affecting cell viability. At a lower concentration of 50 µg/mL, the materials were used to assess cell migration. Among them, the CMC-MCP complex significantly promoted cell migration. Additionally, CMC-MCP treatment led to increased expression levels of matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of metalloproteinases (TIMP-1 and 2), which are key regulators in the wound healing process. These findings suggest that the CMC-MCP complex has potential as an economical, safe, and effective biological dressing for promoting wound healing. Further studies are recommended to explore its interaction with other healing-related factors, such as nutrients and growth factors, to better understand its influence on various stages of tissue repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.